欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
FR/V/0224/002
药品名称
ZIPYRAN XL Tablets for dogs
活性成分
febantel 525.0 mg
praziquantel 175.0 mg
pyrantel 175.0 mg
剂型
Tablet
上市许可持有人
Laboratorios CALIER
参考成员国 - 产品名称
France (FR)
13573
互认成员国 - 产品名称
Greece (GR)
Bulgaria (BG)
许可日期
2014/02/26
最近更新日期
2020/10/16
药物ATC编码
QP52AA51 praziquantel, combinations
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
Line extension - Annex II Reg. (EC) No. 1084/2003
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final SPC
|
1b-spc_tc
Date of last change:2020/04/28
Final SPC
|
1b-spc_cl
Date of last change:2020/04/28
Final PL
|
12986-D90-pl-final
Date of last change:2017/02/20
Final PL
|
13573-D90-pl-final
Date of last change:2017/02/20
Final Labelling
|
12986-D90-label-final
Date of last change:2017/02/10
Final Labelling
|
13573-D90-label-final
Date of last change:2017/02/10
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase